Overexpression of sphingosine kinase 1 in liver reduces triglyceride content in mice fed a low but not high-fat diet


Autoria(s): Kowalski,GM; Kloehn,J; Burch,ML; Selathurai,A; Hamley,S; Bayol,SAM; Lamon,S; Watt,MJ; Lee-Young,RS; McConville,MJ; Bruce, CR
Data(s)

01/02/2015

Resumo

 Hepatic insulin resistance is a major risk factor for the development of type 2 diabetes and is associated with the accumulation of lipids, including diacylglycerol (DAG), triacylglycerols (TAG) and ceramide. There is evidence that enzymes involved in ceramide or sphingolipid metabolism may have a role in regulating concentrations of glycerolipids such as DAG and TAG. Here we have investigated the role of sphingosine kinase (SphK) in regulating hepatic lipid levels. We show that mice on a high-fat high-sucrose diet (HFHS) displayed glucose intolerance, elevated liver TAG and DAG, and a reduction in total hepatic SphK activity. Reduced SphK activity correlated with downregulation of SphK1, but not SphK2 expression, and was not associated with altered ceramide levels. The role of SphK1 was further investigated by overexpressing this isoform in the liver of mice in vivo. On a low-fat diet (LFD) mice overexpressing liver SphK1, displayed reduced hepatic TAG synthesis and total TAG levels, but with no change to DAG or ceramide. These mice also exhibited no change in gluconeogenesis, glycogenolysis or glucose tolerance. Similarly, overexpression of SphK1 had no effect on the pattern of endogenous glucose production determined during a glucose tolerance test. Under HFHS conditions, normalization of liver SphK activity to levels observed in LFD controls did not alter hepatic TAG concentrations. Furthermore, DAG, ceramide and glucose tolerance were also unaffected. In conclusion, our data suggest that SphK1 plays an important role in regulating TAG metabolism under LFD conditions.

Identificador

http://hdl.handle.net/10536/DRO/DU:30069040

Idioma(s)

eng

Publicador

Elsevier BV

Relação

NHMRC 1023570

http://dro.deakin.edu.au/eserv/DU:30069040/lamon-overexpressionof-2015.pdf

http://dx.doi.org/10.1016/j.bbalip.2014.12.002

Direitos

2015, Elsevier BV

Palavras-Chave #Ceramide #Diacylglycerol #Glucose tolerance #Liver #Sphingosine kinase 1 #Triacylglycerol
Tipo

Journal Article